Mike K. Whelan

2 Royal College Street, NW1-0NH London
London, ENG NW10NH, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Delivering Pandemic Vaccines in 100 Days - What Will It Take?

Delivering Pandemic Vaccines in 100 Days - What Will It Take?

Journal: The New England journal of medicine

Published: March 06, 2022

The impact of the COVID-19 pandemic on UK medical education. A nationwide student survey.

The impact of the COVID-19 pandemic on UK medical education. A nationwide student survey.

Journal: Medical teacher

Published: August 24, 2021

Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.

Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) standardized template for collection of key information for benefit-risk assessment of live-attenuated viral vaccines.

Journal: Vaccine

Published: September 04, 2020

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines.

Journal: Vaccine

Published: July 07, 2020

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.

The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines.

Journal: Vaccine

Published: June 10, 2020

Correction to: Developing vaccines against epidemic-prone emerging infectious diseases.

Correction to: Developing vaccines against epidemic-prone emerging infectious diseases.

Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Published: January 10, 2020

Developing vaccines against epidemic-prone emerging infectious diseases.

Developing vaccines against epidemic-prone emerging infectious diseases.

Journal: Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz

Published: November 29, 2019

Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.

Influenza Vaccine Research funded by the European Commission FP7-Health-2013-Innovation-1 project.

Journal: Vaccine

Published: May 23, 2016

Assembly Pathway of Hepatitis B Core Virus-like Particles from Genetically Fused Dimers.

Assembly Pathway of Hepatitis B Core Virus-like Particles from Genetically Fused Dimers.

Journal: The Journal of biological chemistry

Published: May 09, 2015

Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins.

Tandem fusion of hepatitis B core antigen allows assembly of virus-like particles in bacteria and plants with enhanced capacity to accommodate foreign proteins.

Journal: PloS one

Published: November 05, 2014

Showing 1-10 of 10

Last Updated: 09/26/2026